SCHEMBL7667111

SCHEMBL7667111

Cc1ccc(Oc2ccc(F)cc2)c(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 7/20 0.43
SLC6A4 P31645 7/20 0.43
KCNH2 Q12809 7/20 0.43
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP3A4 P08684 2/20 0.40
SCN9A Q15858 1/20 0.38
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
S1PR4 O95977 1/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
S1PR2 O95136 1/20 0.36
TRPA1 O75762 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7672764 0.86 HTR2A (0.46) HTR2ASLC6A4KCNH2CYP1A2CYP2C19
SCHEMBL7667163 0.84 ALDH1A1 (0.47) S1PR4LMNAKMT2AL3MBTL1MEN1
SCHEMBL7666787 0.83 MAPT (0.43) HTR2ASLC6A4KCNH2HTR2CHTR2B
SCHEMBL7668891 0.80 HTR2A (0.41) HTR2ASLC6A4KCNH2CYP1A2CYP2C19
SCHEMBL7666802 0.80 TRPA1 (0.44) SLC6A4KCNH2S1PR4KMT2ATRPA1
SCHEMBL7659649 0.79 ADORA1 (0.34) HTR2ASLC6A4KCNH2S1PR4
SCHEMBL6293301 0.73 HSPB1 (0.43) HTR2ASLC6A4KCNH2LMNAL3MBTL1
SCHEMBL3949976 0.72 TGFBR1 (0.41) SCN9AS1PR4
SCHEMBL7671126 0.72 ALDH1A1 (0.49) LMNAHTT
SCHEMBL22199135 0.71 S1PR4 (0.51) HTR2ASLC6A4KCNH2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed